John Rex, AZ to Present at Anti-Infectives Meeting on July 10-11, 2014, in Boston

Unknown error: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in decode_entities() (line 349 of /var/www/presspoint1/includes/
Printer-friendly versionPrinter-friendly version

John Rex, Vice President and Head of Infection, Global Medicines Development, AstraZeneca to Present at the 11th Anti-Infectives Partnering and Deal-Making Conference on July 10-11, 2014, in Boston, MA

Boston, MA, USA., May 8, 2014 - (PressReleasePoint) - John Rex, Vice President and Head of Infection, Global Medicines Development at AstraZeneca will be a speaker and panelist at the 11th Anti-Infectives Partnering and Deal-Making Conference on July 10-11, 2014, in Boston, MA, by GTCBio.
GTCBio’s Anti-Infectives Partnering and Deal-Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

The conference will discuss antibiotic valuation & reimbursements, pricing strategies, current trends and recent deals, investment and seed stage funding opportunities, government collaborations, non-dilutive funding, evolution of the regulatory framework and pathways for limited use. Participants include Yoav Golan, Tufts University School of Medicine; Michael N. Dudley, Rempex Pharmaceuticals/ The Medicines Company; Michael Eichberg, Achaogen; Barry Eisenstein, Cubist Pharmaceuticals; Mark Goldberger, Abbvie; Peter Hammann, Sanofi-Aventis Deutschland GmbH; Elizabeth Jungman, The Pew Charitable Trusts; Joseph Larsen, BARDA; Kevin Outterson, Boston University; Alex White, Roche; Barrett Thornhill, Antimicrobial Innovation Alliance; Benjamin Thorner, Merck Research Laboratories and many more!

This conference is also part of the Infectious Diseases World Summit 2014, which consists of this and two other conferences: 
1) 12th Vaccines Research & Development: All Things Considered Conference 
2) 3rd Annual Influenza Research and Development Conference

For more information, please visit

Press Contact:
Kristen Starkey
635 W. Foothill Blvd | Monrovia, CA 91016
Email partially hidden to block spam. Please use the contact form here.
Contact Kristen Starkey
Email the contact person for this press release. Do not send spam or irrelevant message.
9 + 2 =

Copy this html code to your website/blog to embed this press release.


Post new comment

9 + 9 =

To prevent automated spam submissions leave this field empty.